{"id":4347,"date":"2024-09-04T11:05:49","date_gmt":"2024-09-04T15:05:49","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/hematology\/?page_id=4347"},"modified":"2024-11-19T14:05:49","modified_gmt":"2024-11-19T19:05:49","slug":"clinical-services","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/","title":{"rendered":"Who We Care For"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-4445\" src=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png\" alt=\"\" width=\"1024\" height=\"341\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png 1024w, https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-300x100.png 300w, https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-768x256.png 768w, https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-600x200.png 600w, https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images.png 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p>We provide expert and compassionate care for adults across seven distinct hematologic conditions. These are CLL\/SLL, lymphoma, multiple myeloma, myeloproliferative neoplasms and bone marrow failure issues (also clonal myeloid abnormalities), acute leukemia, stem cell transplantation and cellular therapy and benign hematology.<\/p>\n<h2>We Focus on Caring for Adults with the Following Conditions<\/h2>\n<p>Given the high demand for hematology services, we must focus on serving adults with complex conditions who benefit most from our team\u2019s expertise, collaborative care, and clinical trials. Please contact us at (984) 974-0000 if you need help.<\/p>\n<span class=\"collapseomatic  colomat-close\" id=\"id681086b76a59e\"  tabindex=\"0\" title=\"&lt;strong&gt;Bone Marrow Transplant and Cellular Therapy&lt;\/strong&gt;\"    ><strong>Bone Marrow Transplant and Cellular Therapy<\/strong><\/span><div id=\"target-id681086b76a59e\" class=\"collapseomatic_content \">\n<p style=\"font-weight: 400\">Patients who are candidates for this therapy should be referred to the BMT clinic. Those referrals are evaluated by a physician with the BMT\/Cellular Therapy Group.<\/p>\n<p style=\"font-weight: 400\">The following patients are not evaluated by the Bone Marrow Transplant and Cellular Therapy Group:<\/p>\n<ul>\n<li>Patients where standard-of-care therapy would not include bone marrow transplantation or cellular therapy. The program will evaluate patients where there is clinical equipoise between conventional and BMT\/cell therapy<\/li>\n<li>Patients who are not currently insured and are not eligible for North Carolina Medicaid<\/li>\n<li>For bone marrow transplantation, patients over the age of 80 are not currently considered for therapy and are not provided a clinic appointment<\/li>\n<\/ul>\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/unclineberger.org\/bmt\/\">Learn More About the BMT Clinic<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76a7c4\"  tabindex=\"0\" title=\"&lt;strong&gt;Chronic Lymphocytic Leukemia (CLL)\/Small Lymphocytic Lymphoma (SLL)&lt;\/strong&gt;\"    ><strong>Chronic Lymphocytic Leukemia (CLL)\/Small Lymphocytic Lymphoma (SLL)<\/strong><\/span><div id=\"target-id681086b76a7c4\" class=\"collapseomatic_content \">\n<ul>\n<li style=\"font-weight: 400\">Patients with CLL\/SLL or those with monoclonal B cells present in peripheral blood or from a tumor biopsy.<\/li>\n<li style=\"font-weight: 400\">Patients should be referred based on the chart provided below.<\/li>\n<\/ul>\n<p style=\"text-align: center\"><a class=\"btn btn-primary btn-lg btn-block  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/07\/Who-We-See-Graphic-黑料网-Division-of-Hematology.pdf\">CLL\/SLL Referral Chart<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76a944\"  tabindex=\"0\" title=\"Leukemia\"    >Leukemia<\/span><div id=\"target-id681086b76a944\" class=\"collapseomatic_content \">\n<ul>\n<li>Patients with acute leukemia or myelodysplastic syndrome should be referred to the leukemia clinic.<\/li>\n<li>Newly diagnosed acute leukemia patients or those with suspected acute leukemia (i.e., circulating blasts, high WBC) should be referred to our Leukemia Expanded Access Program (LEAP).\n<ul>\n<li>LEAP allows for patients to be seen within 24-48 hours of referral so that patients can be evaluated, undergo any diagnostic testing necessary, and can be safely managed and monitored while awaiting for their specific diagnostic tests and genomic profile.<\/li>\n<li>A new patient provider appointment can be scheduled 1-2 weeks after newly diagnosed acute leukemia patients are seen in LEAP.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg btn-block  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/unclineberger.org\/leukemia\/\">Learn More About Leukemia<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76aa0c\"  tabindex=\"0\" title=\"Lymphoma\"    >Lymphoma<\/span><div id=\"target-id681086b76aa0c\" class=\"collapseomatic_content \">\n<ul>\n<li>\n<p style=\"font-weight: 400\">Patients with IgM monoclonal gammopathies (M-spikes) should be referred to 黑料网 malignant hematology, attention Dr. Chris Dittus in the lymphoma clinic, since these are more often associated with lymphomas than plasma cell disorders.<\/p>\n<\/li>\n<li>Patients presenting with the following conditions will not be evaluated by our program, as they do not fall under the category of plasma cell disorders:\n<ul>\n<li>Abnormal serum free light chains without an M-spike, and with ratios that are outside lab-reported normal range but within normal when adjusted for GFR per Rognvaldsson et al in <em>Blood Cancer J\u00a0<\/em> This non-pathologic state stems from reduced renal excretion by light chains and not an actual plasma cell disorder.\n<ol>\n<li>46-2.62 when eGFR 45-59 ml\/min<\/li>\n<li>48-3.38 when eGFR 30-44 ml\/min<\/li>\n<li>54-3.30 when eGFR &lt;30\u00a0ml\/min<\/li>\n<\/ol>\n<\/li>\n<li>\n<p style=\"font-weight: 400\">Polyclonal gammopathy, which is a state that represents non-specific activation of the immune system usually due to infection, autoimmune disease, or other inflammatory disorder not stemming from an intrinsic abnormality in plasma cells<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg btn-block  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/unclineberger.org\/lymphoma\/\">Learn More About Lymphoma<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76aac0\"  tabindex=\"0\" title=\"Multiple Myeloma\"    >Multiple Myeloma<\/span><div id=\"target-id681086b76aac0\" class=\"collapseomatic_content \">\n<ul>\n<li>\n<p style=\"font-weight: 400\"><u>Likely low-risk monoclonal gammopathy of uncertain significance:<\/u><\/p>\n<ul>\n<li><strong>Patients being referred within the 黑料网 system<\/strong>: Patients within the 黑料网 system with small M-spikes (non-IgM and &lt;1.5 g\/dL), normal or mildly abnormal serum free light chain ratios (&lt;10 and &gt;0.1), and no clinical signs or symptoms to suggest an active plasma cell disorder such as multiple myeloma or amyloidosis, should be referred as an\u00a0<u>e-consult <\/u>to malignant hematology.<\/li>\n<li><strong>Patients referred from outside the 黑料网 system<\/strong>: Patients meeting above criteria will have their chart reviewed by a physician within the plasma cell dyscrasia group when the referral is received.\u00a0 Patients with what appears to be low-risk monoclonal gammopathy of uncertain significance (MGUS) will be declined referral, given the extremely low-risk nature of that disorder (&lt;1% annual risk of progression to active multiple myeloma) and the lack of need for specialist evaluation or further workup such as imaging or bone marrow biopsy.\u00a0 Other patients will be scheduled for a clinic evaluation with the plasma cell dyscrasia group.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg btn-block  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/unclineberger.org\/myeloma\/\">Learn More About Myeloma<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76ab97\"  tabindex=\"0\" title=\"Myeloproliferative Neoplasms\"    >Myeloproliferative Neoplasms<\/span><div id=\"target-id681086b76ab97\" class=\"collapseomatic_content \">\n<ul>\n<li style=\"font-weight: 400\">For patients with myeloproliferative neoplasms or non-high grade MDS, referral should be made to the MPN clinic.<\/li>\n<li style=\"font-weight: 400\">Patients with the following parameters will not be seen in the MPN clinic:\n<ul>\n<li>Asymptomatic patients with Hgb &gt; 8, PLT &gt; 50K, ANC &gt; 1K with &lt; 5% circulating blasts. These individuals should undergo a bone marrow evaluation locally and then serial assessment of the peripheral blood count by CBC every 3-6 months until progression.<\/li>\n<li>Isolated neutropenia, anemia or thrombocytopenia. These patients should be referred to benign hematology locally for diagnosis and management.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg btn-block  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/unclineberger.org\/leukemia\/\">Learn More About Myeloproliferative Neoplasms<\/a>\n<\/div>\n<span class=\"collapseomatic \" id=\"id681086b76ac6d\"  tabindex=\"0\" title=\"Benign Hematology\"    >Benign Hematology<\/span><div id=\"target-id681086b76ac6d\" class=\"collapseomatic_content \">\n<p style=\"font-weight: 400\">Faculty in the Section have varied clinical interests that have led to the development of a number of successful multidisciplinary clinical care programs, such as:<\/p>\n<div class=\"row  oscitas-bootstrap-container\">\n<div class=\"col-lg-6 col-md-6 col-xs-12 col-sm-12 oscitas-bootstrap-container\">\n<ul style=\"padding-left: 0;list-style-type: none\">\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/htcenter\/\">Harold Roberts Hemophilia and Thrombosis Center<\/a><\/li>\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/hhtcenter\/\">Hereditary Hemorrhagic Telangiectsia Center of Excellence<\/a><\/li>\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/sickle-cell-program\/\">Sickle Cell Disease Program<\/a><\/li>\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/htcenter\/patient-care\/clotting-disorders\/athletes-and-blood-clots-program\/\">Athletes and Thrombosis Program<\/a><\/li>\n<li><\/div><\/li>\n<\/ul>\n<div class=\"col-lg-6 col-md-6 col-xs-12 col-sm-12 oscitas-bootstrap-container\">\n<ul style=\"padding-left: 0;list-style-type: none\">\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/htcenter\/patient-care\/women-and-girls-with-bleeding-disorders-clinic\/\">Women and Girls with Bleeding Disorders Program<\/a><\/li>\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/htcenter\/patient-care\/clotting-disorders\/dvt-pe-transition-clinic\/\">VTE Transitions clinic (previously called DVT walk-in clinic)<\/a><\/li>\n<li style=\"padding: 10px;border-bottom-width: 1px;border-bottom-style: solid;border-bottom-color: #e1e1e1\"><a href=\"https:\/\/www.med.unc.edu\/hhtcenter\/about-hht\/anemia-and-iron\/\">Iron Deficiency Clinic<\/a><\/li>\n<li><\/div><\/li>\n<\/ul>\n<\/div>\n<p>In an effort to facilitate faculty to focus their clinical care efforts in their chosen areas of interest\/expertise, we have developed\/implemented a number of approaches and workflows:<\/p>\n<ul>\n<li>All referrals to the benign hematology clinic are triaged by the medical director for appropriateness<\/li>\n<li>Referrals that align with the clinical interests of section faculty are scheduled with the appropriate providers<\/li>\n<li>Given the increasing demand for E-Consult, we have identified the most common eConsult questions to us and developed templates for 7 specific diagnoses that can be safely evaluated as E-Consult. The objective is to ensure that requesting physicians provide the necessary information for us to render an opinion in an efficient and timely fashion. We will expand on this and include additional diagnoses collaboratively with our malignant hematology faculty soon. This will allow us to focus on preferred diagnoses in clinic while also providing care of other hematological diagnoses that do not fit with the identified interests of section faculty.<\/li>\n<li>Individuals with these seven specific diagnoses within the 黑料网 system should be referred for an e-consult with benign hematology.<\/li>\n<li>Created a collaboration with Dr. Bonkovsky at Atrium Health\/Wake Forest Baptist hospital, whereby all referral for porphyrias and related diagnoses will be directly referred to Dr. Bonkovsky. Dr. Bonkovsky is nationally renowned for his expertise in porphyrias.<\/li>\n<\/ul>\n<\/div>\n<div class=\"row  oscitas-bootstrap-container\">\n<div class=\"col-lg-6 col-md-12 col-xs-12 col-sm-12 oscitas-bootstrap-container\">\n<p style=\"text-align: right\"><a class=\"btn btn-primary btn-lg  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/referrals\/\">Refer A Patient<\/a>\n<\/div>\n<div class=\"col-lg-6 col-md-12 col-xs-12 col-sm-12 oscitas-bootstrap-container\">\n<a class=\"btn btn-primary btn-lg  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/e-consults\/\">E-Consults<\/a>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>We provide expert and compassionate care for adults across seven distinct hematologic conditions. These are CLL\/SLL, lymphoma, multiple myeloma, myeloproliferative neoplasms and bone marrow failure issues (also clonal myeloid abnormalities), acute leukemia, stem cell transplantation and cellular therapy and benign hematology. We Focus on Caring for Adults with the Following Conditions Given the high demand &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\" aria-label=\"Read more about Who We Care For\">Read more<\/a><\/p>\n","protected":false},"author":112673,"featured_media":0,"parent":2256,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-4347","page","type-page","status-publish","hentry","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Who We Care For - Division of Hematology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Who We Care For - Division of Hematology\" \/>\n<meta property=\"og:description\" content=\"We provide expert and compassionate care for adults across seven distinct hematologic conditions. These are CLL\/SLL, lymphoma, multiple myeloma, myeloproliferative neoplasms and bone marrow failure issues (also clonal myeloid abnormalities), acute leukemia, stem cell transplantation and cellular therapy and benign hematology. We Focus on Caring for Adults with the Following Conditions Given the high demand &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Division of Hematology\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T19:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\",\"name\":\"Who We Care For - Division of Hematology\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png\",\"datePublished\":\"2024-09-04T15:05:49+00:00\",\"dateModified\":\"2024-11-19T19:05:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images.png\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images.png\",\"width\":1080,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Care\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Who We Care For\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/\",\"name\":\"Division of Hematology\",\"description\":\"Department of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/hematology\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Who We Care For - Division of Hematology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/","og_locale":"en_US","og_type":"article","og_title":"Who We Care For - Division of Hematology","og_description":"We provide expert and compassionate care for adults across seven distinct hematologic conditions. These are CLL\/SLL, lymphoma, multiple myeloma, myeloproliferative neoplasms and bone marrow failure issues (also clonal myeloid abnormalities), acute leukemia, stem cell transplantation and cellular therapy and benign hematology. We Focus on Caring for Adults with the Following Conditions Given the high demand &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/","og_site_name":"Division of Hematology","article_modified_time":"2024-11-19T19:05:49+00:00","og_image":[{"url":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/","url":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/","name":"Who We Care For - Division of Hematology","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images-1024x341.png","datePublished":"2024-09-04T15:05:49+00:00","dateModified":"2024-11-19T19:05:49+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images.png","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-content\/uploads\/sites\/1285\/2024\/11\/hem-PC-DOM-Division-Banner-Images.png","width":1080,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/clinical-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/hematology\/"},{"@type":"ListItem","position":2,"name":"Patient Care","item":"https:\/\/www.med.unc.edu\/medicine\/hematology\/patient-care\/"},{"@type":"ListItem","position":3,"name":"Who We Care For"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/hematology\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/hematology\/","name":"Division of Hematology","description":"Department of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/hematology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/pages\/4347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/users\/112673"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/comments?post=4347"}],"version-history":[{"count":17,"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/pages\/4347\/revisions"}],"predecessor-version":[{"id":4453,"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/pages\/4347\/revisions\/4453"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/pages\/2256"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/hematology\/wp-json\/wp\/v2\/media?parent=4347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}